The development of improved typhoid vaccines to prevent antibiotic-resistant typhoid fever in developing countries is a high global public health priority. The potential use of S. Typhi as a bioterror agent has added an additional reason to study this important global pathogen. The goal of this project is to characterize, at the mucosal and systemic levels, both short and long-term humoral and cell-mediated immunity (CMI) induced by oral immunization with the licensed attenuated S. Typhi Ty21a vaccine and to explore the interactions between Ty21a immunization and the gut microbiota. The development of improved live oral typhoid vaccines has been hampered by a lack of detailed information of the specific determinants of protective immunity to S. Typhi infection. Moreover, the effector and memory immune responses to S. Typhi in circulation and in the gut microenvironment have not been characterized. Since the gastrointestinal tract is the site of entry of S. Typhi, the presence of effective and sustained immune responses in the local microenvironment are likely to be pivotal in protection from infection. Results from studies in typhoid patients and vaccine trials with attenuated S. Typhi strains in adults suggest that antibodies (Ab) to common S. Typhi antigens appear to play a protective role against S. Typhi infection, however, it is not known if such Abs mediate protection or serve as a surrogate for the more dominant protective cellular mediated immunity (CMI) resulting in the elimination of this iritracellular S. Typhi. In spite of the fact that children stand to benefit the most from improved typhoid vaccines, only cursory information is available concerning serum Ab levels and, to our knowledge, there are no reports on the induction of antibody secreting cells (ASC), memory B cells (BM) or CMI in this group of individuals. The elderly represent another population group that is understudied in terms of the generation of immune responses to this oral vaccine, as no information is available concerning the induction of either Ab or CMI responses. The growing awareness of the importance of the gut microbiota in health and disease has also raised the question as to the influence of the complex community of microorganisms that inhabit the gastrointestinal tract in oral immunization and vice versa. Therefore, this application in addition to examining the immune response, will also examine the interactions between immune responses to Ty21a immunization and the gut microbiota in children, adults and the elderly. Overall this application addresses two important aspects of the development of immunity to S. Typhi.

Public Health Relevance

The development of improved typhoid vaccines to prevent antibiotic-resistant typhoid fever in developing countries is a high global public health priority. In this project we propose to examine the immunological response to oral S. Typhi vaccines as well as their effect on the bacteria that reside inside the human gastrointestinal tract. We will compare and contrast the observed effects in children, adults and the elderly.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI082655-05
Application #
8485525
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
5
Fiscal Year
2013
Total Cost
$583,927
Indirect Cost
$179,040
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Salerno-Goncalves, Rosangela; Rezwan, Tasmia; Sztein, Marcelo B (2014) B cells modulate mucosal associated invariant T cell immune responses. Front Immunol 4:511
Fiorentino, Maria; Levine, Myron M; Sztein, Marcelo B et al. (2014) Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release. PLoS One 9:e85211
Waddington, Claire S; Darton, Thomas C; Jones, Claire et al. (2014) An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution. Clin Infect Dis 58:1230-40
Wahid, Rezwanul; Zafar, Shah J; McArthur, Monica A et al. (2014) Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Clin Vaccine Immunol 21:427-34
McArthur, Monica A; Sztein, Marcelo B; Edelman, Robert (2013) Dengue vaccines: recent developments, ongoing challenges and current candidates. Expert Rev Vaccines 12:933-53
Eloe-Fadrosh, Emiley A; McArthur, Monica A; Seekatz, Anna M et al. (2013) Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses. PLoS One 8:e62026
Barry, Eileen M; Pasetti, Marcela F; Sztein, Marcelo B et al. (2013) Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol 10:245-55
Eloe-Fadrosh, Emiley A; Rasko, David A (2013) The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 64:145-63
McArthur, Monica A; Sztein, Marcelo B (2013) Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol 146:140-52
Wahid, Rezwanul; Simon, Jakub K; Picking, Wendy L et al. (2013) Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. Clin Immunol 148:35-43

Showing the most recent 10 out of 24 publications